Today, President Obama Declares September National Ovarian Cancer Awareness Month. “Today, cancer research is on the cusp of major breakthroughs, and it is of critical national importance that we accelerate this progress and keep reaching for prevention, treatment, and a cure. Each September, in honor of the women who have been taken by ovarian cancer … Continued
Follow OCRFA on Facebook, Twitter and Instagram and join the conversation at #30DaysofTeal! September 1: Help us tell 100,000 women the symptoms of ovarian cancer. Share our graphic and link on social media today. Learn more about the symptoms of ovarian cancer. P.S. – Wear Teal Day is TOMORROW! Don’t forget to wear your best … Continued
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society … Continued
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins, Star Jones, Congresswoman Carolyn Maloney, Rebecca Minkoff, Cathy Moriarty-Gentile, Elin Nordegren, Molly Sims, Jill … Continued
View events happening across the country during September, National Ovarian Cancer Awareness month!
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins, Star Jones, Congresswoman Carolyn Maloney, Rebecca Minkoff, Cathy Moriarty-Gentile, Elin Nordegren, Molly Sims, … Continued
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, … Continued
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in … Continued
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you … Continued
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. … Continued
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and … Continued
Every year cancer researchers and doctors gather at several professional meetings to present and discuss the latest and most important advances in basic, translational and clinical cancer research. OCRF Scientific Advisory Committee member Douglas A. Levine, MD, highlighted research relevant to ovarian cancer patients presented at the American Society of Clinical Oncology (ASCO), as well … Continued
Get email updates about research news, action alerts, and ways to join the fight.
